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http://dx.doi.org/10.1016/j.stemcr.2017.03.014SUMMARYThe striking rise of obesity-related metabolic disorders has focused attention on adipocytes as critical mediators of disease phenotypes. To
better understand the role played by excess adipose inmetabolic dysfunction it is crucial to decipher the transcriptional underpinnings of
the low-grade adipose inflammation characteristic of diseases such as type 2 diabetes. Through employing a comparative transcriptomics
approach,we identified IRF1 as differentially regulated betweenprimary and in vitro-derived geneticallymatched adipocytes. This suggests
a role as amediator of adipocyte inflammatory phenotypes, similar to its function in other tissues. Utilizing adipose-derivedmesenchymal
progenitors we subsequently demonstrated that expression of IRF1 in adipocytes indeed contributes to upregulation of inflammatory pro-
cesses, both invitroand invivo.Thishighlights IRF1’s relevance toobesity-related inflammationand the resultantmetabolicdysregulation.INTRODUCTION
Obesity is a disease in which the energy reserve stored
in the adipose tissue has increased excessively to cause
adverse health effects. Adipocytes play a critical role in
the regulation of triglyceride storage, glucose homeostasis,
and energy expenditure. Excess adipose can disrupt this
regulation. Obesity-related metabolic diseases, including
type 2 diabetes mellitus (T2DM), have reached epidemic
proportions and have been recognized as a leading contrib-
utor to morbidity and premature mortality (Ogden et al.,
2012). More than 85% of people diagnosed with T2DM
are overweight or obese (ADA, 2012).
Adipocyte biology has garnered increased attention
because of this. Chronic low-grade inflammation of adi-
pose tissue has emerged as an important contributor to
obesity-induced insulin resistance (Gregor and Hotamisli-
gil, 2011). Inflammation of adipose tissue is thought to
occur due to nutrient overload in adipocytes, activating in-
flammatory pathways and leading to the recruitment of
immune cells. In the context of obesity, adipocytes are a
critical source of inflammatory chemokines that contribute
to metabolic disease.
Transcriptional profiling of adipocytes has identified
several regulators of adipogenesis (transcription factors,1164 Stem Cell Reports j Vol. 8 j 1164–1173 j May 9, 2017 j ª 2017 The Aut
This is an open access article under the CC BY-NC-ND license (http://creativlong non-coding RNAs, and microRNAs) (Urs et al.,
2004). Unfortunately, few transcriptional regulators of adi-
pose inflammation have been identified due to the in vitro
nature of these studies. Therefore, the mechanistic under-
pinnings of how adipocytes contribute to metabolic
diseases such as T2DM are underappreciated. To identify
determinants of adipose inflammation, we transcription-
ally profiled primary human adipocytes isolated from
obese donors. We then compared expression data with
in vitro-derived adipocytes. By focusing on differentially
regulated transcription factors with a known function in
immune response, we prioritized interferon regulatory fac-
tor 1 (IRF1). Subsequently we examined its role in adipose
inflammation.RESULTS
Comparative Expression Analysis of Primary versus
In Vitro-Derived Adipocytes
For expression analysis of primary and in vitro-derived ad-
ipocytes, we obtained whole subcutaneous adipose tissue
from two obese females (body mass index >30; 41 and 59
years old) undergoing elective abdominoplasty. Primary
adipocytes were isolated from whole adipose tissue. Wehors.
ecommons.org/licenses/by-nc-nd/4.0/).
verified the integrity of the adipocytes using fluorescence
microscopy, showing the large unilocular lipid droplet
typical of white adipocytes (Figure 1A). In addition, we iso-
lated adipose stromovascular cells (ASCs) from one of the
donors (59 years). The ASCs were subsequently differenti-
ated into adipocytes at >90% efficiency (Figures 1B and
S1A), and adipocyte-specific gene expression wasmeasured
(Figure S1B).
RNA was extracted from the above cell types and sub-
jected to whole-genome microarray analysis. Hierarchical
clustering accurately grouped replicates of adipocytes,
ASCs, and ASC adipocytes, with significant expression dif-
ferences between groups (Figure 1C). We identified 1,749
genes with >1.7-fold higher abundance in primary adipo-
cytes versus ASC adipocytes at a 0.1% false discovery
rate (FDR) (Table S1). Gene ontology enrichment analysis
for the primary adipocyte-enriched genes was consis-
tent with a phenotype of inflammation, with enriched
terms including ‘‘response to type I interferon,’’ ‘‘immune
response,’’ and ‘‘positive regulation of chemotaxis’’ (Table
S2). Genes with increased expression in the aforemen-
tioned pathways reflect a spectrum of inflammatory medi-
ators, including interferon-regulated transcription factors
(IRF1, IRF8), chemokines (CCL2/MCP1, CCL8), cytokines
(IL6, IL8), Toll-like receptors (TLR1, TLR3), and inflamma-
some components (NLRP3). This inflammatory signature
was not observed in undifferentiated ASCs either.
To control for contribution of stromovascular fraction
cells (SVFs) to the inflammatory expression signature we
isolated the SVF pellet, as contaminating immune cell tran-
scripts should be identified in this fraction as well. Of the
1,749 transcripts identified to be specifically upregulated
in primary adipocytes compared with ASC adipocytes,
1,009 were more abundant in the primary adipocytes
compared with the SVFs, providing a conservative estimate
for the fraction of geneswith an adipocyte origin (Table S3).
This list of 1,009 genes includes all of the inflammatory
mediators listed above. The highest expressed immunoreg-
ulatory transcription factor in primary compared with
ASC adipocytes was IRF1 (14.3-fold, p = 7.50 3 1023). We
sought to validate this result in two additional datasets.
Comparing four additional primary adipocyte samples
with three unmatched ASC adipocytes, we found a 33-fold
upregulation of IRF1 in the primary adipocytes (Figure 1D).
To ascertain that increased IRF1 expression is specific to
obesity, we analyzed a publicly available dataset (GEO data-
set GDS3602) comparing primary adipocytes from ten lean
versus ten obese individuals, and found a 3.72-fold increase
in IRF1 expression in adipocytes from obese individuals
(Figure 1E; Lee et al., 2005). A large portion of genes overex-
pressed in obese individuals from this dataset (1.7-fold,
0.1% FDR) (Table S4) overlaps with genes we found upregu-
lated in primary adipocytes (Figure S1C). The list of overlap-ping genes includes, but is not limited to, inflammatory
genes such as the aforementioned IRF1, CCL2, CCL8, IL6,
and IL8 (Table S5).
Expression of IRF1 in Adipocytes Activates the
Immune Response
Utilizing lentivirus to express a doxycycline-inducible
transgene, we devised a scheme to express IRF1 in ASC ad-
ipocytes (IRF1 adipocytes) (Figure 2A). After several days of
doxycycline treatment we confirmed the expression of
ectopic IRF1 (Figure S2A). Chromatin immunoprecipita-
tion qPCR (ChIP-qPCR) revealed that ectopic IRF1 binds
near genes that contain an IRF1-binding motif proximal
to their promoter (PARP14, IFIT3, ISG15), and IRF1 binding
correlates with increased expression of these genes (Fig-
ure 2B). There is no expression difference or IRF1 binding
in genes without this motif (OAS3, ZNF74). When IRF1 is
not overexpressed, we do not see this effect (Figure S2B).
In differentiated adipocytes, IRF1 overexpression affected
the mRNA levels of relatively few genes (138 upregulated,
80 downregulated, 1.7-fold, 0.1% FDR) (Figure 2C and
Table S5). The majority of upregulated genes in IRF1 adipo-
cytes are associatedwith innate immunity, includingmajor
histocompatibility complex (MHC) class I receptors, inter-
feron-responsive genes, and chemotactic cytokines. Im-
mune response-associated genes found to be upregulated
in IRF1 adipocytes are also increased in primary adipocytes
compared with ASC adipocytes. Furthermore, 103 of the
138 differentially regulated genes were previously reported
as known interferon-responsive genes, confirming that we
are observing a bona fide interferon-like response in IRF1
adipocytes (Samarajiwa et al., 2009). This leads us to
conclude that ASC adipocytes expressing IRF1more closely
resemble primary human obese adipocytes.
IRF1 Alters Metabolism and Lipid Droplet
Composition of Adipocytes In Vitro
Experimental evidence shows that the interferon response
pathway associates with altered adipocyte metabolism, as
treatment of in vitro-derived adipocytes with interferon-g
induces insulin resistance (McGillicuddy et al., 2009).
The known role of IRF1 in the interferon response and
the upregulation of inflammatory genes in IRF adipocytes
led us to hypothesize that IRF1 contributes to adipose
inflammation. To further characterize IRF1 activation, we
performed a multiplex ELISA to determine levels of cyto-
kines and adipokines released by IRF1 adipocytes (Figures
3A and S2C). We found secretion of pro-inflammatory cy-
tokines interleukin-6 (IL-6) and IL-8, as well as monocyte
chemotactic protein 1 (MCP-1), were significantly elevated
in IRF1 adipocytes concomitant with the increase in RNA.
We also found these genes to be upregulated in obese indi-
viduals (Figure S2D).Stem Cell Reports j Vol. 8 j 1164–1173 j May 9, 2017 1165
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Figure 1. Primary and ASC-Adipocyte Integrity and Transcriptional Profiling
(A) Primary adipocytes isolated from whole adipose. Adipocytes were stained with DAPI to visualize the DNA (blue), BoDIPY to stain the
lipid droplet (green), and LavaCell to stain the plasma membrane (red), and visualized by wide-field microscopy.
(B) ASCs were differentiated into adipocytes and stained with DAPI to visualize the DNA (blue), BoDIPY to stain lipids (green), and an
antibody to visualize C/EBPa (red).
(C) Hierarchical clustering and heatmap representation of transcriptional profiles (mRNA) from ASCs, ASC adipocytes, and primary adi-
pocytes. Probe sets are colored according to expression level.
(D) Gene expression of IRF1 in ASCs (n = 3), ASC adipocytes (n = 3), and primary adipocytes (n = 4).
(E) Gene expression of IRF1 in isolated subcutaneous adipocytes of lean (n = 10) and obese (n = 10) individuals.
For all graphs, error bars represent SD, experiments were performed in biological triplicates and statistically significant p values are
denoted by asterisks (*p% 0.05, **p% 0.005).
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Figure 2. IRF1 Expression Leads to an Inflammatory Gene Signature
(A) Experimental scheme to ectopically express IRF1 in mature ASC adipocytes.
(B) ChIP-qPCR (n = 3) was performed for IRF1 at putative binding sites (H3K4me1 bound IRF1 motif) (PARP14, IFIT3, ISG15). OAS3 and
ZNF74 represent a negative control site where IRF1 is not predicted to bind. Signals are expressed as percentage of total chromatin input.
The heatmap represents expression levels of these genes in IRF1 and rtTA adipocytes.
(C) Hierarchical clustering and heatmap representation of transcriptional profiles (mRNA) from rtTA adipocytes, IRF1 adipocytes, and
primary adipocytes. Probe sets are colored according to expression level. The highest expressed 30% of genes in IRF-1 adipocytes have
been expanded to highlight their inflammatory nature.
Error bars represent SD, experiments were performed in biological triplicates, and statistically significant p values are denoted by asterisks
(*p% 0.05, **p% 0.005).Since obese adipocytes display reduced lipolysis in
vivo, we performed a lipolysis assay to measure the ability
of IRF1 adipocytes to catabolize intracellular lipids. In
response to b-adrenergic stimulation, IRF1 adipocytes
were unable to increase triglyceride hydrolysis, unlike con-
trol cells (Figures 3B and S2E). To assess insulin sensitivity,
we performed a glucose uptake assay. Expression of IRF1
abrogates insulin-mediated glucose uptake in ASC adipo-cytes, consistent with the increase in pro-inflammatory
signaling and altered lipid metabolism (Figure 3C).
Unlike their in vivo counterparts, in vitro-derived adipo-
cytes typically display multilocular lipid droplets. After
several days of IRF1 expression, ASC adipocytes demon-
strate a transition from a multilocular to unilocular state
and the average size of the largest lipid droplet increases
significantly (Figure 3D). The total intracellular triglycerideStem Cell Reports j Vol. 8 j 1164–1173 j May 9, 2017 1167
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Figure 3. IRF1 Expression Impairs Adipocyte Metabolism and Affects Lipid Composition
(A) Multiplex ELISA assay was utilized to measure cytokines secreted into medium by IRF1 adipocytes compared with control adipocytes.
(B) Glycerol release into the medium in response to forskolin (FSK)-activated lipolysis was measured in IRF1 and rtTA adipocytes.
(C) Radiolabeled glucose uptake was measured in response to insulin.
(D) After 5 days of IRF1 expression, IRF1 adipocytes become unilocular. Lipid droplet size was measured after staining with the lipid dye
BoDIPY (green) and the nuclear dye DAPI (blue). CPM, counts per minute.
(legend continued on next page)
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(TG) content in IRF1 adipocytes is similar to that of ASC
adipocytes, indicating no lipid uptake or synthesis pheno-
type (Figure 3E). These data suggest that IRF1 has a spe-
cific effect on lipid droplet coalescence. Next we used tan-
dem mass spectroscopy to assess lipid composition. We
found that intracellular TGs in IRF1 adipocytes exhibit
a greater degree of saturation, with fewer double bonds
(p = 73 106) and longer carbon chains (p = 83 106) (Fig-
ures 3F and S2F).IRF1 Expression in Adipose Leads to Localized
Inflammation In Vivo
IRF1-adipocyte phenotypes in vitro are consistent with
those reported for inflamed primary adipose tissue; hence,
we tested whether IRF1 also contributes to adipose inflam-
mation in vivo. We transfected the adipogenic mouse cell
line 3T3-F442A with a human IRF1 (hIRF1) overexpres-
sion construct or control (Figure S3A). These cells were
injected subcutaneously onto the flanks of nude mice. Af-
ter 6 weeks of engraftment, ectopic fat pads were excised
and assayed for inflammatory phenotypes (Figure 4A). We
observed a significant increase in the number of macro-
phages localizing to implants expressing IRF1 compared
with control implants or autologous white adipose tissue
(WAT) (Figures 4B, 3C, S3B, and S3C). IRF1 implants ex-
hibited increased expression of MHC class II and MCP-1
compared with autologous WAT, as well as an increase
in the macrophage-specific gene F4/80, in line with the
immunostaining shown above (Figure 4D). Inexplicably,
we did find noticeable differences in gene expression
between autologous WAT of hIRF1 and rtTA (reverse tetra-
cycline-controlled transactivator) mice despite using bio-
logical triplicates. While this is worrying, there is consis-
tency with the staining data. Altogether these data are
consistent with both the transcriptional analysis of pri-
mary adipocytes and in vitro assays performed in ASC
adipocytes, and imply that IRF1 contributes to adipose
inflammation.DISCUSSION
The mechanistic underpinnings of obesity’s contribution
to chronic adipose inflammation are poorly understood.
Few transcriptional regulators have been identified that
activate adipose inflammatory cascades in vivo. Progress
is impeded by the lack of direct experimentation on pri-
mary adipocytes and reliance on in vitro systems that(E) Total intracellular triglycerides (TG) were measured in IRF1 and r
(F) Tandem mass spectrometric profiles of triglyceride composition fo
Error bars represent SD, experiments were performed in biological tripl
(*p% 0.05, **p% 0.005). n = 3 for each experiment.cannot recapitulate obesity, endocrine regulation, and im-
mune system interactions. However, previous studies have
implicated the major inflammatory transcription factors
nuclear factor kB and activator protein 1 as possible medi-
ators of adipose inflammation associated with obesity,
but the mechanism for activation is unclear (Suganami
et al., 2007; Osborn and Olefsky, 2012). This study found
several inflammatory mediators differentially expressed
in primary versus differentiated adipocytes, most notably
IRF1. This result was verified in an independent dataset
showing an increase of IRF1 in obese individuals when
compared with lean individuals. IRF1 has been identified
as a transcriptional activator of type I interferon gene acti-
vation in response to viral infection (Harada et al., 1989).
Additionally it has been observed that IRF4 represses early
stages of adipogenesis (Eguchi et al., 2008) and modulates
adipocyte lipid handling in vitro (Eguchi et al., 2011), sug-
gesting a significant role for IRFs in adipose biology. How-
ever, there has been no study of IRF1 in human adipocytes.
Expression of IRF1 in ASC adipocytes is sufficient to acti-
vate genes in the interferon response and inflammation
pathways. Despite few transcriptional changes, IRF1 over-
expression leads to phenotypes associated with metabolic
disease, including insulin resistance and attenuated lipol-
ysis. Further supporting its role in adipose inflammation,
expression of IRF1 in 3T3-derived mouse adipose in vivo
increases macrophage infiltration. We also demonstrate
elevated MCP-1, which leads to inflammation and is asso-
ciated with obesity, insulin resistance, and altered adipo-
cyte metabolism (Kanda et al., 2006; Kim et al., 2006).
Lipidomic profiling of human subjects has revealed that
the level of circulating saturated TGs is strongly correlated
with insulin resistance and is a predictor of T2DM develop-
ment (Rhee et al., 2011; Wu¨rtz et al., 2012). One striking
phenotype of IRF adipocytes is the change in length and
saturation level of TGs. The finding that expression of an
immunoregulatory transcription factor leads to changes
in composition of lipid droplet TGs is surprising. This
finding in conjunction with our lipidomics data suggests
that inflammation triggers production ofmore highly satu-
rated fatty acids, in turn driving ER stress and further
inflammation in a feedback loop (Wang et al., 2006). IRF1
adipocytes also acquire a unilocular lipid droplet, charac-
teristic of primary adipocytes but absent in all in vitro
models. Longer-chain, saturated TGs in IRF1 adipocytes
could increase hydrophobicity of the intracellular lipids,
potentiating the observed coalescence of lipids into a single
large droplet.tTA adipocytes.
r both IRF1 and rtTA adipocytes.
icates, and statistically significant p values are denoted by asterisks
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Figure 4. IRF1 Leads to Increased Inflammation In Vivo
(A) 3T3-F442A cells were transduced with either rtTA alone, or human IRF1 (hIRF1) containing lentiviral particles, and were injected into
6-week-old nude mice (n = 4). Six weeks after injection, ectopic subcutaneous fat pads (dashed circles) were excised.
(B) Ectopic fat explants (EXP) were stained with DAPI (blue) and probed with a-F4/80 (green) and a-PLIN1 (red).
(C) F4/80-positive cells were counted relative to DAPI staining foci in hIRF1 explants versus rtTA explants and autologous WAT (see
Figure S3C). A minimum of 104 DAPI foci were counted for each experiment.
(D) qPCR was used to assess expression of hIRF1 and inflammation-associated mouse genes in both explants and autologous WAT (n = 3).
Error bars represent SD, experiments were performed in biological triplicates, and statistically significant p values are denoted by asterisks
(*p% 0.05, **p% 0.005).Our data suggest that IRF1 expression in human adipo-
cytes contributes to adipose inflammation and insulin
resistance.EXPERIMENTAL PROCEDURES
Primary Adipocyte Isolation and ASC Cell Culture/
Differentiation
Primary human adipocytes were obtained from discarded adipose
tissue from two female elective abdominoplasty patients.Whole ad-
ipose was chopped up and digested with Liberase Blendzyme
(Roche) for 1 hr at 37C, forced through a 250-mmfilter, and centri-
fuged. The floating adipocyte fraction was washed with PBS and1170 Stem Cell Reports j Vol. 8 j 1164–1173 j May 9, 2017re-collected. The stromovascular cell pellet was washed twice
with PBS and plated onto gelatin-coated plates in ASC growth me-
dium (DMEM, 10% fetal bovine serum [FBS], 1% penicillin-strepto-
mycin, and 2.5 ng/mL basic fibroblast growth factor [Aldevron]).
ASCs were brought to homogeneity by passaging and when 95%
confluent, adipocyte medium (DMEM, 10% FBS, 1% penicillin-
streptomycin, 0.1 mM dexamethasone, 10 mg/mL insulin, 0.5 mM
rosiglitazone, 250 mM 3-isobutyl-1-methylxanthine [IBMX]) was
added for 5 days. On day 6, ASCs were switched to adipocyte me-
dium without IBMX for 14 additional days.
RNA Extraction/qRT-PCR/Transcriptional Profiling
Total RNA from all cell preparations was extracted using TRIzol
(Invitrogen). RNA quality was determined using an RNA nanochip
on a Bioanalyzer (Agilent Technologies). RNA was converted to
cDNA using the Superscript First-Strand III kit (Invitrogen) and
qRT-PCRwas carried out using a RealplexMastercycler (Eppendorf)
with Quantifast-SYBR Green Mastermix (Qiagen). Primer sets are
listed in supplemental Experimental Procedures.
RNA samples were processed by Asuragen and microarray anal-
ysis was performed on the Affymetrix Human Genome U133
Plus 2.0 Array. Arrays were hybridized overnight at 50C,
washed, stained, and scanned on a GeneChip Scanner 3000. Mi-
croarray data was analyzed using R/Bioconductor (http://www.
bioconductor.org). Raw data were normalized by robust multi-
array averaging (Bolstad et al., 2003) using a custom Chip
Description File from the Michigan Microarray Lab (http://
brainarray.mbni.med.umich.edu, version 13). Primary adipocyte
RNA is from Zenbio, cat. #RNAmi-Q10-1, RNAmi-Q10-2, and
RNA-Q10-3. GEO data were taken from Lee et al. (2005), dataset
record GEO: GDS3602.
Microarray Gene and Sample Clustering
To select aminimally biased set of genes for hierarchical clustering,
we used the R package limma (Smyth, 2005) to test for differential
expression across all ten pairwise comparisons between biologi-
cally distinct samples: primary adipocytes (59 and 41 years of
age), ASCs (59 years), ASC adipocytes (59 years), and the pelleted
SVF from disassociated adipose tissue (59 years). Hierarchical clus-
tering was performed on the 2,489 probe sets with five or more
significantly different pairwise comparisons (FDR = 0.001). The
hmap function in the seriation R package (Hahsler et al., 2008)
was used to generate the heatmap.
Production of Inducible Transgenes/Lentivirus
Transduction
Doxycycline-inducible lentiviral Gateway (Invitrogen) vector
containing IRF1 was constructed by PCR amplification from
verified cDNA clones (GenBank: NM_002198) (GeneCopoeia),
and standard TOPO cloning (Invitrogen) techniques were used
to generate entry clones. The IRF1 construct was transduced
via calcium chloride transfection into HEK293T cells as previ-
ously described (al Yacoub et al., 2007). Media containing viral
supernatant was collected, filtered, and used to infect ASC adi-
pocytes. Infection efficiency was measured as compared by co-
infection with a GFP lentiviral construct. Expression of IRF1
was induced by addition of doxycycline (1 mg/mL final) to the
adipogenic medium.
ChIP
ASC adipocytes were crosslinked in 1% formaldehyde and
quenched with glycine (200 mM final). Cells were washed several
times in PBS. ChIP-qPCR was performed with an antibody against
IRF1 (Santa Cruz Biotechnology, sc-497) as previously described
(Camahort et al., 2007). All ChIPs were graphed as percentage
of total chromatin input. qPCR was performed as described
above.
Protein Normalization
Protein concentration used to normalize other assays was
measured using the Bradford protein assay (Bio-Rad).Metabolic Assays
For glucose uptake, after 5 days of IRF1 expression ASC adipocytes
were serum starved in low-glucose DMEM containing 0.2% BSA
overnight. Cells were incubated in KRH buffer (120 mM NaCl,
5 mM KCl, 1 mM MgSO4, 0.3 mM CaCl2 and 10 mM HEPES
[pH 7.4]) in the presence or absence of 100 nM insulin for
30 min at 37C. Non-specific uptake was measured in the presence
of 10 mM cytochalasin B. Glucose uptake was measured by incu-
bating cells with 0.5 mCi/mL1 2-deoxy-D-[3H]glucose (Perkin-
Elmer) for 5 min at 37C.
For glycerol release, after 5 days of IRF1 expression ASC-adipo-
cyte cells were starved in DMEM with 1% FBS for 1 hr and then
incubated in Hank’s balanced salt solution with 2% fatty acid-
free BSAwith forskolin for 1 hr (0 mM, 1 mM, and 10 mM). The incu-
bation medium was collected for glycerol measurement using a
colorimetric assay kit (Sigma).
All assays were performed in biological triplicates and normal-
ized to protein.
Multiplex ELISA Assay
Medium was collected 5 days after IRF1 expression and ELISA was
performed on a Luminex 200 analyzer using theHumanAdipocyte
Multiplex Panel (Millipore, HADCYMAG-61K) as per manufac-
turer’s instructions. The assay was performed in biological tripli-
cate and normalized to protein.
Triglyceride Analysis/Lipidomics
Total TG levels were measured using a colorimetric assay
kit (Cayman Chemicals). Protein concentration was used to
normalize intracellular TG content. For lipidomics, after 5 days
of transgene expression ASC adipocytes were washed with
fresh medium. Ice-cold isopropanol was added, and cells were
scraped and collected into cold tubes. Extracts were incubated
for 1 hr at 4C, than vortexed and centrifuged at 2,300 3 g for
10 min. The supernatant was used for mass spectroscopic anal-
ysis. All data were acquired using a Sciex 4000 QTRAP mass spec-
trometer as previously described (Rhee et al., 2011). MultiQuant
software (version 1.1; Applied Biosystems/Sciex) was used for
automated peak integration, and peaks were manually reviewed
for quality of integration. Internal standard peak areas were
monitored for quality control and used to normalize analyte
peak areas.
For the transducedASCswe averaged six replicates formetabolite
abundance of 44 TG species and computed an abundance ratio of
the two (IRF1/rtTA). We built a regression model, predicting the
abundance ratio using number of double bonds and total number
of carbon atoms as variables as well as an interaction term to assess
whether the relationship with number of double bonds varies with
carbon number. Statistical significance of regression coefficients
was assessed using the F test.
Transplantation
Differentiated 3T3-F442A preadipocytes were transduced with
hIRF-1 or rtTA lentivirus at day 7 and injected subcutaneously on
the backs of 6-week-old female NCr nude mice (n = 4, Taconic).
The cells developed into mature adipocytes over the next 6 weeks.
Mice were euthanized to harvest fat pads which were fixed,Stem Cell Reports j Vol. 8 j 1164–1173 j May 9, 2017 1171
embedded in paraffin, and stained after sectioning. Harvard Uni-
versity Animal Care and Use Committee approved all animal
procedures.
Immunostaining
The following antibodies and dilutions were used: a-CEBPA 1:100
(Santa Cruz, sc-61), a-PLIN1 1:200 (Sigma, P1873), and a-F4/80
1:200 (eBioscience, 14-4801-81). Lipid droplets were stained using
BoDIPY neutral lipid dye (Thermo Fisher, D-3922), cell membranes
using LavaCell dye (Active Motif, 15004), and cell nuclei with
DAPI. Images were acquired using a Nikon Eclipse Ti-Smicroscope.
BothNIS-Elements and ImageJ software packages were used for im-
age analysis.
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